Patents Assigned to Elixir Pharmaceuticals, Inc.
  • SirT inhibitors that bind to NAD
    Patent number: 8486990
    Abstract: Compound of formula (I) and methods of treating disorders by administering a compound of formula (I) are described herein. Examples of disorders include neoplastic disorders, fat-cell related disorders, neurodegenerative disorders, and metabolic disorders.
    Type: Grant
    Filed: April 14, 2009
    Date of Patent: July 16, 2013
    Assignee: Elixir Pharmaceuticals, Inc.
    Inventors: Andrew Napper, Peter DiStefano, Rory A. Curtis, Jeffrey Hixon, Thomas McDonagh, L. Julie Huber, Jonathan M. Solomon, Russell J. Thomas, Jean-Francois Pons
  • Therapeutic compounds and uses thereof
    Patent number: 7897765
    Abstract: Compounds of formula (I) are described herein The compounds can be used, for example, to modulate growth hormone secretagogue receptor (GHS-R). In some instances, the compounds can be used to treat obesity.
    Type: Grant
    Filed: February 9, 2009
    Date of Patent: March 1, 2011
    Assignee: Elixir Pharmaceuticals, Inc.
    Inventors: Peter Distefano, Andrew Napper, Rory Curtis, Jay Luly, Manuel A. Navia, Russell J. Thomas, Jean-Francois Pons, Jeffrey O. Saunders
  • Sulfonamide compounds and uses thereof
    Patent number: 7829589
    Abstract: Compounds that modulate GHS-R are described, for examples compounds formula (I)
    Type: Grant
    Filed: November 29, 2006
    Date of Patent: November 9, 2010
    Assignee: Elixir Pharmaceuticals, Inc.
    Inventors: Jeffrey O. Saunders, Thomas Coulter, Paul Mortenson, Manuel A. Navia, Jean-Francois Pons
  • Cytochrome c acetylation
    Patent number: 7771961
    Abstract: Modulation of cytochrome c acetylation, e.g., with a SIR polypeptide, enables interventions that modulate lifespan regulation and cell proliferation, e.g., by modulating apoptosis and/or mitochondrial function such as respiration.
    Type: Grant
    Filed: July 10, 2009
    Date of Patent: August 10, 2010
    Assignee: Elixir Pharmaceuticals, Inc
    Inventors: L. Julie Huber, Jonathan M. Solomon
  • Cytochrome c acetylation
    Patent number: 7575883
    Abstract: Modulation of cytochrome c acetylation, e.g., with a SIR polypeptide, enables interventions that modulate lifespan regulation and cell proliferation, e.g., by modulating apoptosis and/or mitochondrial function such as respiration.
    Type: Grant
    Filed: December 15, 2003
    Date of Patent: August 18, 2009
    Assignee: Elixir Pharmaceuticals, Inc.
    Inventors: L. Julie Huber, Jonathan M. Solomon
  • Therapeutic compounds and uses thereof
    Patent number: 7504506
    Abstract: Compounds of formula (I) are described herein The compounds can be used, for example, to modulate growth hormone secretagogue receptor (GHS-R). In some instances, the compounds can be used to treat obesity.
    Type: Grant
    Filed: November 4, 2004
    Date of Patent: March 17, 2009
    Assignee: Elixir Pharmaceuticals, Inc.
    Inventors: Peter Distefano, Andrew Napper, Rory Curtis, Jay Luly, Manuel A. Navia, Russell J. Thomas, Jean-Francois Pons, Jeffrey O. Saunders